Serum concentration of hepatocyte growth factor (HGF) in oral squamous cell carcinoma before and after surgery. Preliminary report

Endokrynologia Polska

Volumn 59, Issue 6, 2008, Pages 467-470

  Borgiel Marek, Halina ^a,b   Kajdaniuk, Dariusz ^b   Niedzielska, Iwona ^a   Kos Kudła, Beata ^b   Tarabura Dragon, Joanna ^c   Marek, Bogdan ^b  

^a Department of Craniomaxillofacial Surgery ^*  (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Voivodeship Specialistic Hospital No 3   (Poland)

Author keywords

Angiogenesis; HCF; Histological grade; Oral squamous cell carcinoma; TNM stage

Indexed keywords

SCATTER FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOFACIAL SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; MAXILLOFACIAL SURGERY; MOUTH CARCINOMA; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; TUMOR MARKERS, BIOLOGICAL;

EID: 60049095358     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Moore SR, Johnson NW. The epidemiology at mouth cancer: a review of global incidence. Oral Disease 2000; 6: 65-74.
2. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-1973.
3. Logullo AF, Nonogaki S, Miguel RE et al. Transforming growth factor beta 1 (TGFβ1) expression in head and neck squamous cell carcinoma in patients as related to prognosis. J Oral Pathol Med 2003; 32: 139-145.
4. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patients. Ann Otol Rhmol Laryngol 1995; 104: 946-954.
5. Casiglia J, Woo SB. A comprehensive review of oral cancer. Cancer 2001; 1: 72-82.
6. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
7. Albo D, Granick MS, Jhala N et al. Angiogenesis in human squ-amous cell carcinomas. Ann Plast Surg 1994; 32: 588-594.
8. Battegay E.J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73: 333-346.
9. Aaronson SA. Growth factors and cancer. Science, 1991; 254: 1146-1153.
10. Kajdaniuk D, Marek B. Insulin-like growth factor I (IGF-I) and neoplasms. Postepy Nauk Medycznych 1999; 1-2: 34-38.
11. Fiedler IL, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-189.
12. Grant DS, Kleinman HK, Goldberg ID et al. Scatter factor induce blood vessel formation in vivo. Proc Natl Arad Sci USA 1993; 90: 1937-1941.
13. Ohshima M, Sakai A, Ito K et al. Hepatocyte growth factor (HGF) in periodontal disease: detection of HGF In gingival crevicular fluid. J Periodontal Res 2002; 37: 8-14.
14. Kan M, Zang GH, Zarnegar R. Hepatocyte growth factor/hepatopoietin A stimulates growth of rat kidney proximal tubulae epithelial cell (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed (RPTE). Biochem Biophys Res Common 1991; 174: 331-337.
15. Bussolino F, Di Renzo MF, Ziche M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641.
16. Chen YS, Wang JT, Chang YF et al. Expression of hepato-cyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 2004; 33: 209-217.
17. Grey AM, Schor AM, Rushton E et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 1989; 86: 2438-2442.
18. Ito A, Nakajima S, Sasaguri Y et al. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinase 1, 2 and 3 in fibroblasts. Br J Cancer 1995; 71: 1039-1045.
19. Doan N, Reher P, Meghji S et al. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J Oral Maxillofac Surg 1999; 57: 409-419.
20. Matsumoto K., Horikoshi M., Rikimaru K. et al. A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med 1989; 18: 498-501.
21. Taniguchi T, Kitamura M, Arai K et al. Increase in circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 1997; 75: 673-677.
22. Yamashita J, Ogawa M, Yamashita S et al. Immu-noreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994; 54: 1630-1633.
23. Siegfried JM, Weissfel d LA, Singh-Kaw P et al. Association of immunoreactive hepatocyte growth factor with poor survival in respectable non-small cell lung cancer. Cancer Res 1997; 57: 433-439.
24. Uchida D, Kawamata H, Omotehara F et al. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 2001; 93: 489-496.
25. Ricort JM, Binoux M. Insulin like growth factor binding protein-3 activates a phosphor-tyrosine phosphatase. Effects of the insulin like growth factor signaling pathway. J Biol Chem 2002; 277: 19448-19454.
26. Tang B, Vu M, Booker T et al. TGFβ1 switches from tumor suppressor to prometastatic factor in model of breast cancer progression. J Clin Invest 2003; 112: 1116-1124.
27. Roberts AB, Wakefield L. The two faces of transforming growth factor β in carcinogenesis. Prot Natl Acad Sci USA 2003; 100: 8621-8623.